NAYA BIOSCIENCES INC (NAYA) Stock Price, Quote, News and Overview
NASDAQ:NAYA - Nasdaq - US44984F4019 - Common Stock - Currency: USD
NAYA Quote, Performance and Key Statistics
1.92
+0.08 (+4.35%)
The current stock price of NAYA is 1.92 USD. In the past month the price decreased by -17.95%.
NAYA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.4 | 227.16B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.86 | 172.95B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.9 | 140.69B | ||
| SYK | STRYKER CORP | 28.42 | 132.26B | ||
| MDT | MEDTRONIC PLC | 15.47 | 105.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.29 | 57.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.3 | 42.05B | ||
| IDXX | IDEXX LABORATORIES INC | 36.58 | 33.35B | ||
| RMD | RESMED INC | 24.08 | 31.27B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.89 | 28.56B | ||
| DXCM | DEXCOM INC | 41.56 | 26.89B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.04 | 22.19B |
Related stock screener links
About NAYA
Company Profile
NAYA Biosciences, Inc. operates a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 25 full-time employees. The company went IPO on 2008-11-11. The Company’s initial pipeline includes two novel Flex-NK Bispecific Antibodies. NY-303: its GPC3-targeted FLEX-NK Bispecific Antibody for Hepatocellular Carcinoma (HCC). NY-338: its CD38-targeted FLEX-NK Bispecific Antibody for Multiple Myeloma (MM) & Autoimmune Diseases. Its lead GPC3-targeting FLEX-NK bispecific antibody is entering Phase I/II clinical trials and positioned as a monotherapy option to address the unmet needs of the of hepatocellular carcinoma (HCC) patients not responding to standard of care with checkpoint inhibitors. INVOcell is its novel, FDA-cleared and CE-marked intravaginal culture (IVC) device. The company offers a viable alternative to vitro fertilization (IVF) that uses the female body for fertilization and incubation, keeping women at the center of the reproductive process.
Company Info
NAYA BIOSCIENCES INC
5582 Broadcast Court
Sarasota FLORIDA US
Employees: 25
Company Website: https://www.invobioscience.com/
Investor Relations: http://www.invobioscience.com/investors/
Phone: 19788789505
NAYA BIOSCIENCES INC / NAYA FAQ
What is the stock price of NAYA BIOSCIENCES INC today?
The current stock price of NAYA is 1.92 USD. The price increased by 4.35% in the last trading session.
What is the ticker symbol for NAYA BIOSCIENCES INC stock?
The exchange symbol of NAYA BIOSCIENCES INC is NAYA and it is listed on the Nasdaq exchange.
On which exchange is NAYA stock listed?
NAYA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for NAYA BIOSCIENCES INC stock?
7 analysts have analysed NAYA and the average price target is 24.48 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 1.92. Check the NAYA BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is NAYA BIOSCIENCES INC worth?
NAYA BIOSCIENCES INC (NAYA) has a market capitalization of 1.29M USD. This makes NAYA a Nano Cap stock.
How many employees does NAYA BIOSCIENCES INC have?
NAYA BIOSCIENCES INC (NAYA) currently has 25 employees.
What are the support and resistance levels for NAYA BIOSCIENCES INC (NAYA) stock?
NAYA BIOSCIENCES INC (NAYA) has a resistance level at 2.04. Check the full technical report for a detailed analysis of NAYA support and resistance levels.
Is NAYA BIOSCIENCES INC (NAYA) expected to grow?
The Revenue of NAYA BIOSCIENCES INC (NAYA) is expected to grow by 125.23% in the next year. Check the estimates tab for more information on the NAYA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy NAYA BIOSCIENCES INC (NAYA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NAYA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NAYA, evaluating the profitability, health, valuation and growth aspects
- NAYA BIOSCIENCES INC (NAYA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NAYA BIOSCIENCES INC (NAYA) Sales and EPS estimates to see what analysts future expectations are.
- NAYA BIOSCIENCES INC (NAYA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NAYA BIOSCIENCES INC (NAYA) Insider and Institutional Ownership to learn about the owners and their transactions.
- NAYA BIOSCIENCES INC (NAYA) Stock Chart to make your own analysis
- NAYA BIOSCIENCES INC (NAYA) Latest news and press-releases to stay up to date.
Does NAYA BIOSCIENCES INC (NAYA) stock pay dividends?
NAYA does not pay a dividend.
When does NAYA BIOSCIENCES INC (NAYA) report earnings?
NAYA BIOSCIENCES INC (NAYA) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of NAYA BIOSCIENCES INC (NAYA)?
NAYA BIOSCIENCES INC (NAYA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.96).
What is the Short Interest ratio of NAYA BIOSCIENCES INC (NAYA) stock?
The outstanding short interest for NAYA BIOSCIENCES INC (NAYA) is 1.68% of its float. Check the ownership tab for more information on the NAYA short interest.
NAYA Technical Analysis
NAYA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to NAYA. NAYA has a bad profitability rating. Also its financial health evaluation is rather negative.
NAYA Financial Highlights
Over the last trailing twelve months NAYA reported a non-GAAP Earnings per Share(EPS) of -2.96. The EPS increased by 76.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.87% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
NAYA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to NAYA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of -3770% and a revenue growth 125.23% for NAYA